BioNTech SE, a biotechnology company, develops and markets immunotherapies for cancer and other infectious diseases. The company is headquartered in Mainz, Germany.
Data last updated: April 10, 2026 at 8:10 AM EDT
Get e-mail RSI alerts when BioNTech SE enters oversold or overbought territory. Free forever.
Add Alert